Mylan CEO Heather Bresch told CNBC on Monday that the pharmaceutical company's global supply chain experienced "minimal disruption" during the coronavirus pandemic. "As Covid hit different areas of the world at different points in time, [being] able to navigate and leverage the different aspect of our supply chain, really allowed us to really have minimal